ClinicalTrials.Veeva

Menu

Cardiac Output Measurement at the Conclusion of Cardiopulmonary Bypass

T

Transonic Systems

Status

Terminated

Conditions

Cardiac Output

Treatments

Device: HCE101 Cardiopulmonary Support Monitor

Study type

Observational

Funder types

Industry
NIH

Identifiers

NCT01103908
2R44HL082022-02 (U.S. NIH Grant/Contract)
TSI-G-HCE101-5A-H

Details and patient eligibility

About

Cardiac output, the amount of blood pumped by the heart in one minute, will be measured in pediatric patients undergoing surgery involving cardiopulmonary bypass (CPB). Cardiac output will be measured after cardiopulmonary bypass using a device that employs ultrasound dilution technology. At times, cardiac output will be measured during a procedure called modified ultrafiltration (MUF). The ultrasound dilution cardiac output measurements will be validated or compared with cardiac output measurements made using other FDA approved techniques and devices.

Enrollment

3 patients

Sex

All

Ages

Under 21 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pediatric patients (age < 21 years)
  • Pediatric patients undergoing surgery involving cardiopulmonary bypass

Exclusion criteria

  • Patients aged > 21 years
  • Patients undergoing surgery "off pump" (not involving cardiopulmonary bypass)

Trial design

3 participants in 1 patient group

Pediatric cardiac output (CO) after CPB
Description:
Cardiac output measurements made in pediatric patients after cardiopulmonary bypass.
Treatment:
Device: HCE101 Cardiopulmonary Support Monitor

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems